In order to evaluate if Lewis glycans were part of N-glycans, we treated the high-grade glioma cell line LN229 with N-glycosylation inhibitors, Tunicamycin (TM) and Swainsonine (SW), and with a specific small interfering RNA (siRNA) targeting MGAT5. This evidence concerns the gene MGAT5 and central nervous system cancer.